Emzor Pharmaceutical Industries Ltd Strategic SWOT Analysis Review [Report Updated: 03012019] Prices from USD $125

08:55 EST 8 Jan 2019 | BioPortfolio Report Blog

Emzor Pharmaceutical Industries Ltd Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Business description A detailed description of the company's operations and business divisions.

Corporate strategy GlobalData's summarization of the company's business strategy.

SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities A list of key manufacturing facilities of the company.


Emzor Pharmaceutical Industries Ltd Emzor, a subsidiary of Emzor Chemists Limited, is a pharmaceutical company that develops, manufactures and markets pharmaceutical products and medical consumables. The company provides analgesics, antiinflammatries, antibiotics, antimalarials, haematinics, and vitamins and dietary supplements. Emzor provides products in various forms such as syrups, oils, drops and tablets, among others. The company's offers its products under Emtrim, Emcillin, Emrozon, Ferrous, Paracetamol, Emzolyn, Lokmal, Maldox Fresh Seas and Omega 3 and other brands. The company has offices in Nigeria, Liberia, India, Mali, Ghana and Sierra Leone. Emzor is headquartered in Lagos, Nigeria.

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Original Article: Emzor Pharmaceutical Industries Ltd Strategic SWOT Analysis Review [Report Updated: 03012019] Prices from USD $125


More From BioPortfolio on "Emzor Pharmaceutical Industries Ltd Strategic SWOT Analysis Review [Report Updated: 03012019] Prices from USD $125"

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...